Americans should not be on a game show in U.S. emergency rooms and ambulances

American Journal of Bioethics

Volumn 10, Issue 10, 2010, Pages 9-10

  Grassley, Chuck ^a  

^a US Senate   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN; POLYMERIZED HEMOGLOBIN; HEMOGLOBIN GLUTAMER 256;

AMBULANCE; DRUG INDUSTRY; EDITORIAL; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; ETHICS; FOOD AND DRUG ADMINISTRATION; HEMORRHAGIC SHOCK; HUMAN; INFORMED CONSENT; METHODOLOGY; MORTALITY; PROFESSIONAL STANDARD; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHOCK, HEMORRHAGIC;

AMBULANCES; BLOOD SUBSTITUTES; DRUG INDUSTRY; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; ETHICS COMMITTEES, RESEARCH; HEMOGLOBINS; HUMANS; INFORMED CONSENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SHOCK, HEMORRHAGIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77958142470     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2010.525165     Document Type: Editorial

References (2)

1. Kipnis, K., N. King, and R. Nelson. 2006. Trials and errors: Barriers to oversight of research conducted under the emergency research consent waiver. IRB: Ethics & Human Research 28(2): 16-19.
2. U.S. Food and Drug Administration Center for Drug Evaluation and Research. 2005. Guidance for industry: Information program on clinical trials for serious or life-threatening diseases and conditions. Available online at http://www.fda.gov/ cder/guidance/4856fnl.htm (Accessed on March 27, 2006).